Gefitinib, but not erlotinib, is a possible inducer of Fra-1-mediated interstitial lung disease

Yasunari Takada, Koichi Matsuo

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Gefitinib, but not erlotinib, is a possible inducer of Fra-1-mediated interstitial lung disease'. Together they form a unique fingerprint.

Medicine & Life Sciences